Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Consultant & Investment GroupAMM:CICO 73 Days Sales Outstanding is 78.69 as of Jun. 2026, which is 2% below its 10-year median of 80.47. GuruFocus rates AMM:CICO with a GF Score™ of 73/100 and a GF Value™ of JOD2.05 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 657 Healthcare Providers & Services companies, The Consultant & Investment Group ranks worse than 80.37% on this metric.
The historical rank and industry rank for The Consultant & Investment Group's Days Sales Outstanding or its related term are showing as below:
AMM:CICO'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.22 Med: 80.47 Max: 89.82
Current: 89.82
During the past 13 years, The Consultant & Investment Group's highest Days Sales Outstanding was 89.82. The lowest was 17.22. And the median was 80.47.
AMM:CICO's Days Sales Outstanding is ranked worse than 80.37% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 45.94
vs AMM:CICO: 89.82
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group Days Sales Outstanding Chart
AMM:CICO vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, The Consultant & Investment Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Consultant & Investment Group Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where The Consultant & Investment Group's Days Sales Outstanding falls into.
The Consultant & Investment Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group (AMM:CICO) has a Days Sales Outstanding of 78.69 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on The Consultant & Investment Group and its competitors. This is near median its historical median of 80.47. Over the past decade, The Consultant & Investment Group's Days Sales Outstanding has ranged from 17.22 to 89.82. According to the industry distribution chart, The Consultant & Investment Group ranks #528 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 80.4%.
Is The Consultant & Investment Group's Days Sales Outstanding too high?
The Consultant & Investment Group's current Days Sales Outstanding of 78.69 is near median its 10-year median of 80.47. Over the past 10 years, this metric has ranged from a low of 17.22 to a high of 89.82. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.94. The Consultant & Investment Group's value of 78.69 is 71.3% above this industry median. Based on the distribution chart, The Consultant & Investment Group ranks #528 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, The Consultant & Investment Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, The Consultant & Investment Group ranks #528 out of 657 companies for Days Sales Outstanding. This places The Consultant & Investment Group in the lower half of its industry. The industry median Days Sales Outstanding is 45.94. The Consultant & Investment Group's value of 78.69 is 71.3% above this benchmark. Historically, The Consultant & Investment Group's own Days Sales Outstanding has ranged from 17.22 to 89.82 over the past decade. While the company's 10-year median is 80.47 vs. the industry median of 45.94, The Consultant & Investment Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.94, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Consultant & Investment Group's current Days Sales Outstanding of 78.69 is 71.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on The Consultant & Investment Group and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Consultant & Investment Group's current Days Sales Outstanding is 78.69, which is near median its own 10-year median of 80.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.05, compared to a current price of JOD1.78 — trading 13.2% below its estimated fair value. The current Days Sales Outstanding is 78.69, which is near median its 10-year median of 80.47 and 71.3% above the Healthcare Providers & Services industry median of 45.94. The Consultant & Investment Group's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current Days Sales Outstanding is 78.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?
Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued.
The current stock price of JOD1.78 is trading 13.2% below its estimated GF Value™ of JOD2.05.
GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.
Key valuation signals for AMM:CICO:
Days Sales Outstanding: 78.69 (near median its 10-year median of 80.47)
GF Value™: JOD2.05 vs. price of JOD1.78 (13.2% below fair value)
Industry Position: 71.3% above the Healthcare Providers & Services median (#528 of 657)
No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
73GF Score
Get the complete analysis for AMM:CICO
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:CICO has been successfully added to your 
